Warner Chilcott Ltd Upgraded "The Deals & Earnings Keep Coming"

Warner Chilcott Ltd (NASDAQ: WCRX) upgrade to a BUY rating by Jefferies & Company, Inc. "We expect WCRX to continue to outperform"

In a research report, Jefferies & Company Inc writes,
"Last Friday Warner Chilcott Ltd announced it had amended it Enablex relationship with Novartis (NVS,CHF55.55, Buy) to acquire full U.S rights. This allows WCRX to optimize the sales effort and benefit from leaner operations. These cost savings should make the deal $0.20 to $0.25
accretive in '11."

WCRX price target increased from $25.00 to $27.00. WCRX closed Friday at $22.60.